OPTIMIZED NUCLEOTIDE SEQUENCES ENCODING SARS-COV-2 ANTIGENS

The present invention relates to optimized nucleotide sequence encoding SARS-COV-2 antigens. These sequences are particularly suitable for use in vaccine compositions for the treatment or prevention of infections caused by a β-coronaviruses, including COVID-19 infections, in a human or animal subjec...

Full description

Saved in:
Bibliographic Details
Main Authors KALNIN, Kirill, DEROSA, Frank, FU, Tong-Ming, CHIVUKULA, Sudha, KARVE, Shrirang, DUBINS, Jeffrey, S, PLITNIK, Timothy, GU, Xiaobo, ZACHARIA, Minnie, SKALESKI, Joseph, A, DIAS, Anusha, TRAN, Khang, Anh, BOEGLIN, Lianne, CASIMIRO, Danilo
Format Patent
LanguageEnglish
French
German
Published 15.03.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to optimized nucleotide sequence encoding SARS-COV-2 antigens. These sequences are particularly suitable for use in vaccine compositions for the treatment or prevention of infections caused by a β-coronaviruses, including COVID-19 infections, in a human or animal subject in need of such treatment.
Bibliography:Application Number: EP20210728750